Difference between revisions of "Roder S, et al. Exp. Hematol. (2001) cited as Ref 317 in DOI: 10.1038/s41392-020-0110-5 (Q9580)"
Jump to navigation
Jump to search
(Created claim: Page(s) (P105): 694-702, #quickstatements; #temporary_batch_1590074839150) |
(Created claim: Fourth Author string (P152): Pahl HL, #quickstatements; #temporary_batch_1590155310798) |
||
| Property / Fourth Author string | |||
| + | Pahl HL | ||
| Property / Fourth Author string: Pahl HL / rank | |||
| + | Normal rank | ||
Latest revision as of 13:49, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Roder S, et al. Exp. Hematol. (2001) cited as Ref 317 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Roder S
0 references
Steimle C
0 references
Meinhardt G
0 references
2001
0 references
Exp. Hematol.
0 references
29
0 references
STAT3 is constitutively active in some patients with Polycythemia rubra vera (English)
0 references
694-702
0 references
Pahl HL
0 references
